Evidence map›Paper›PMID 31406500›Full record

ArticleChinese medicine2019

A network pharmacology-based study on the anti-hepatoma effect of Radix

Yi Luo, Yu Feng, Lei Song, Gan-Qing He, Sha Li, Sha-Sha Bai, Yu-Jie Huang, Si-Ying Li, Mohammed M Almutairi, Hong-Lian Shi and 2 more

Abstract read
In one paragraph

Article in Chinese medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Reveal the mechanisms of prescriptions for liver cancer' treatment based on two illustrious senior TCM physicians.Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2023
    Article
  6. Article
  7. Article
  8. Celastrol promotes apoptotic cell death in children neuroblastoma cells through caspases dependent pathway.Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2022
    Article
  9. Aging · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yi Luo1Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, 510405 China.
Yu Feng2Department of Traumatology, General Hospital of Ningxia Medical University, Yinchuan, 750004 China.
Lei Song1Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, 510405 China.
Gan-Qing He4Department of Gastroenterology, Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, 501260 China.
Sha Li5School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Sha-Sha Bai1Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, 510405 China.
Yu-Jie Huang1Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, 510405 China.
Si-Ying Li6Department of Pharmacology & Toxicology, University of Kansas, Lawrence, KS USA.
Mohammed M Almutairi6Department of Pharmacology & Toxicology, University of Kansas, Lawrence, KS USA.
Hong-Lian Shi6Department of Pharmacology & Toxicology, University of Kansas, Lawrence, KS USA.
Qi Wang1Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, 510405 China.
Ming Hong1Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, 510405 China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRadix

methodsIn this study, we aimed to elucidate the underlying molecular mechanisms of RSM in the treatment of HCC using a network pharmacology approach. In vivo and in vitro experiments were also performed to validate the therapeutic effects of RSM on HCC.

resultsIn total, 62 active compounds from RSM and 72 HCC-related targets were identified through network pharmacological analysis. RSM was found to play a critical role in HCC via multiple targets and pathways, especially the EGFR and PI3K/AKT signaling pathways. In addition, RSM was found to suppress HCC cell proliferation, and impair cancer cell migration and invasion in vitro. Flow cytometry analysis revealed that RSM induced cell cycle G2/M arrest and apoptosis, and western blot analysis showed that RSM up-regulated the expression of BAX and down-regulated the expression of Bcl-2 in MHCC97-H and HepG2 cells. Furthermore, RSM administration down-regulated the expression of EGFR, PI3K, and p-AKT proteins, whereas the total AKT level was not altered. Finally, the results of our in vivo experiments confirmed the therapeutic effects of RSM on HCC in nude mice.

conclusionsWe provide an integrative network pharmacology approach, in combination with in vitro and in vivo experiments, to illustrate the underlying therapeutic mechanisms of RSM action on HCC.

Indexed as

Hepatocellular carcinomaNetwork pharmacologyRadix Salviae Miltiorrhizae

Identifiers

PMID31406500
PMCPMC6685170

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.